Emerging Role of Gamma Delta T-cells in Immunotherapies

USD 750

* Required Fields

USD 750


Be the first to review this product

This edition of the Future Tech TOE focuses on the emerging role of gamma delta T-cell platforms in immunotherapy applications. This service provides valuable insights across the global adoptive T-cell therapy landscape, while outlining the key unmet needs across this space. Apart from profiling key innovators in this space, the research encompasses application overview, clinical trial analysis, summary of key technology drivers and challenges, IP overview, research funding scenario, and strategic insights across gamma delta T-cell platforms.

The Future Tech TechVision Opportunity Engine (TOE) captures emerging innovations in research and development, or profile existing technologies which have seen a resurgence in terms of new markets and applications. It usually provides a technology overview, drivers, challenges, research and development, analyst insights and key patent information. In some cases, technology convergence scenarios and future growth opportunities are outlined. It covers innovations and technologies in a variety of industry spaces including manufacturing, sensors, electronics, information and communications technologies, networks, lighting technologies, healthcare, medical devices, materials and coatings, and developments in the energy sector that contribute toward a sustainable and greener world.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Chimeric antigen receptor T-cell therapy, gamma delta T-cells, γδ T-cells, adoptive T-cell therapies, cancer immunotherapy, targeted therapy, CAR T therapy

Table of Contents

Emerging Role of Gamma Delta T-cells in ImmunotherapiesOverviewEmerging Role of T-cell-based ImmunotherapiesAddressing Unmet Needs in Adoptive T-cell Therapiesγδ T-cells are Likely to have Increasing Applications in Cancer Immunotherapyγδ T-cells are Likely to have Increasing Applications in Cancer Immunotherapy (Contd.)Summary of Clinical Trials Involving γδ T-cellsSummary of Clinical Trials Involving γδ T-cells (Contd.)Innovation TrackerRole of Gamma Delta T-cells in Immune Response MediationNext Generation T-cell TherapiesApplications of Gamma Delta T-cell Therapy in Oncology and Immunological DiseasesNovel Isolation Technique for Gamma Delta T-cellsImpact Analysis and AssessmentOverview of Key Technology Drivers and RestraintsAntigen Recognition Diversity Drives Increasing Applications of Gamma Delta T-cell-based Therapies Leading Technological Restraints Include Sub-optimal Clinical PerformanceIP Analysis and Strategic InsightsChina Leads the Global IP Landscape for Gamma Delta T-cellsAllergy, Infectious Diseases and Cancer are Leading Research reas for Gamma Delta T-cellsStrategic Initiatives for Enhancing Gamma Delta T-cell TherapiesAppendixSummary of Key Contacts




Related Research

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Release Date : 29-Nov-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.